Nanosphere-mediated delivery of vascular endothelial growth factor gene for therapeutic angiogenesis in mouse ischemic limbs

Biomaterials

Volumn 29, Issue 8, 2008, Pages 1109-1117

  Kang, Sun Woong ^a   Lim, Hee Won ^a   Seo, Sang Woo ^a,b   Jeon, Oju ^a   Lee, Minhyung ^a   Kim, Byung Soo ^a  

^a Hanyang University   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Angiogenesis; Gene therapy; Nanoparticle; Poly(lactic co glycolic acid)

Indexed keywords

CYTOTOXICITY; DNA SEQUENCES; NANOPARTICLES; NANOSPHERES; RATS;

ANGIOGENESIS; GENE THERAPY;

GENE EXPRESSION;

DRUG CARRIER; NANOSPHERE; PLASMID DNA; POLYETHYLENEIMINE; POLYGLACTIN; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; ISCHEMIA; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SUSTAINED RELEASE FORMULATION;

ANIMALS; APOPTOSIS; BIOLOGICAL AVAILABILITY; CELL SURVIVAL; DNA; EXTREMITIES; FEMALE; FIBROBLASTS; GENE THERAPY; GENE TRANSFER TECHNIQUES; GLYCOLATES; HUMANS; IMINES; ISCHEMIA; MICE; MICE, INBRED C57BL; MICROSCOPY, ELECTRON, SCANNING; MUSCLE, SKELETAL; NANOSPHERES; NEOVASCULARIZATION, PHYSIOLOGIC; PARTICLE SIZE; POLYETHYLENES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 37349021515     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2007.11.004     Document Type: Article

References (31)

1. Cavazzana-Calvo M., Hacein-Bey S., De Saint Basile G., Gross F., Yvon E., Nusbaum P., et al. Gene therapy of human severe combined immune deficiency (SCID)-X1 disease. Science 288 (2000) 669-672
2. Davidson B.L., Stein C.S., Heth J.A., Martins I., Kotin R.M., Derksen T.A., et al. Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system. Proc Natl Acad Sci USA 97 (2000) 3428-3432
3. Auricchio A., Rivera V.M., Clackson T., O'Connor E.E., Maguire A.M., Tolentino M.J., et al. Pharmacological regulation of protein expression from adeno-associated viral vectors in the eye. Mol Ther 2 (2002) 238-242
4. Krisky D.M., Wolfe D., Goins W.F., Marconi P.C., Ramakrishnan R., Mata M., et al. Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons. Gene Ther 12 (1998) 1593-1603
5. Christiano R. Viral and non-viral vectors for cancer gene therapy. Anticancer Res 18 (1998) 3142-3246
6. Chonn A., and Cullis P.R. Recent advances in liposome technologies and their applications for systemic gene delivery. Adv Drug Del Rev 30 (1998) 73-83
7. Bonadio J., Goldstein S.A., and Levy R.J. Gene therapy for tissue repair and regeneration. Adv Drug Del Rev 33 (1998) 53-69
8. Labhasetwar V., Bonadio J., Goldstein S., Chen W., and Levy R.J. A DNA controlled-release coating for gene transfer: transfection in skeletal and cardiac muscle. J Pharm Sci 87 (1998) 1347-1350
9. Shea L.D., Smiley E., Bonadio J., and Mooney D.J. DNA delivery from polymer matrices for tissue engineering. Nat Biotechnol 17 (1999) 551-554
10. Smith T., Zhang Y., and Niven R. Toward development of a non-viral gene therapeutic. Adv Drug Del Rev 26 (1997) 135-150
11. Mathiowitz E., Jacob J.S., Jong Y.S., Carino G.P., Chickering D.E., Chaturvedi P., et al. Biologically erodable microspheres as potential oral drug delivery systems. Nature 27 (1997) 410-414
12. Hedley M.L., Curley J., and Urban R. Microspheres containing plasmid encoding antigenes elicit cytotoxic T-cell responses. Nat Med 4 (1998) 365-368
13. Labhasetwar V., Bonadio J., Goldstein A.S., and Levy R.J. Gene transfection using biodegradable nanospheres: results in tissue culture and a rat osteotomy model. Colloids Surf B: Biointerfaces 16 (1999) 281-290
14. Lee M., Choi J.S., Choi M.J., Pak Y.K., Rhee B.D., and Ko K.S. DNA delivery to the mitochondria sites using mitochondrial leader peptide conjugated polyethylenimine. J Drug Target 15 (2007) 115-122
15. Lee M., Rentz J., Bikram M., Han S., Bull D.A., and Kim S.W. Hypoxia-inducible VEGF gene delivery to ischemic myocardium using water-soluble lipopolymer. Gene Ther 10 (2003) 1535-1542
16. Abdallah B., Hassan A., Benoist C., Goula D., Behr J.P., and Demeneix B.A. A powerful non-viral vector for in vivo gene transfer into the adult mammalian brain: polyethylenimine. Hum Gene Ther 7 (1996) 1947-1954
17. Godbey W.T., Wu K.K., and Mikos A.G. Size matters: molecular weight affects the efficiency of poly(ethylenimine) as a gene delivery vehicle. J Biomed Mater Res 45 (1999) 268-275
18. Benns J.M., Maheshwari A., Furgeson D.Y., Mahato R.I., and Kim S.W. Folate-PEG-folate-graft-polyethylenimine-based gene delivery. J Drug Target 9 (2001) 123-139
19. Panyam J., Zhou W.Z., Prabha S., Sahoo S.K., and Labhasetwar V. Rapid endo-lysosomal escape of poly(d,l-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery. FASEB J 16 (2002) 1217-1226
20. Stern M., Ulirich K., Geddes D.M., and Alton E.W.F.W. Poly(d,l-lactide-co-glycolide)/DNA microspheres to facilitate prolonged transgene expression in airway epithelium in vitro, ex vivo and in vivo. Gene Ther 10 (2003) 1282-1288
21. Jeon O., Kang S.W., Lim H.W., Chung J.H., and Kim B.S. Long-term and zero-order release of basic fibroblast growth factor from heparin-conjugated poly(l-lactide-co-glycolide) nanospheres and fibrin gel. Biomaterials 27 (2006) 1598-1607
22. Lemmouchi Y., Schacht E., Kageruka P., De Deken R., Diarra B., Diall O., et al. Biodegradable polyesters for controlled release of trypanocidal drugs: in vitro and in vivo studies. Biomaterials 19 (1998) 1827-1837
23. Jain R.A. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials 23 (2000) 2475-2490
24. Cohen H., Levy R.J., Gao J., Fishbein I., Kousaev V., Sosnowski S., et al. Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles. Gene Ther 7 (2000) 1896-1905
25. Yi F., Wu H., and Jia G.L. Formulation and characterization of poly(d,l-lactide-co-glycolide) nanoparticle containing vascular endothelial growth factor for gene delivery. J Clin Pharm Ther 31 (2006) 43-48
26. Jeon O., Lim H.W., Song S.J., Lee M., and Kim B.S. Poly(l-lactide-co-glycolide) nanospheres conjugated with a nuclear localization signal for delivery of plasmid DNA. J Drug Target 15 (2007) 190-198
27. Han S.I., Kim B.S., Kang S.W., Shirai H., and Im S.S. Cellular interactions and degradation of aliphatic poly(ester amide)s derived from glycine and/or 4-amino butyric acid. Biomaterials 24 (2003) 3453-3462
28. Jeon O., Kang S.W., Lim H.W., Choi D., Kim D.I., Lee S.H., et al. Synergistic effect of sustained delivery of basic fibroblast growth factor and bone marrow mononuclear cell transplantation on angiogenesis in mouse ischemic limbs. Biomaterials 27 (2006) 1617-1625
29. Jiang H., Zhang T., and Sun X. Vascular endothelial growth factor gene delivery by magnetic DNA nanospheres ameliorates limb ischemia in rabbits. J Surg Res 126 (2005) 48-54
30. Folkman J., and Shing Y. Angiogenesis. J Biol Chem 267 (1992) 10931-10934
31. Dvorak H.F., Brown L.F., Detmar M., and Dvorak A.M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146 (1995) 1029-1039